Select Medical Holdings Corporation (SEM)
ROA
Obliczenia
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
---|---|---|---|---|---|---|---|---|---|
Zysk netto (ttm) | w tys. USD | 234 718 | 216 500 | 196 216 | 174 143 | 153 385 | 175 165 | 223 369 | 329 416 |
Aktywa razem | w tys. USD | 7 689 630 | 7 684 010 | 7 701 870 | 7 699 740 | 7 665 290 | 7 554 980 | 7 551 660 | 7 535 940 |
ROA | 3,05% | 2,82% | 2,55% | 2,26% | 2,00% | 2,32% | 2,96% | 4,37% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $234 718K ÷ $7 689 630K
= 3,05%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Select Medical Holdings Corporation
SEM
3,05%
Acadia Healthcare Company Inc
ACHC
-0,40%
Encompass Health Corp
EHC
5,73%
Ensign Group Inc
ENSG
5,01%
HCA Healthcare Inc
HCA
9,33%
National Healthcare Corp.
NHC
5,10%
Pediatrix Medical Group Inc
MD
-2,72%
Tenet Healthcare Corp.
THC
2,16%
Universal Health Services, Inc.
UHS
5,14%